How Dermatologists Use Technology in Skin Cancer Detection

Dermatologists diagnose and manage conditions that affect the skin, hair, and nails, and they play a central role in skin cancer detection. They examine spots, track changes over time, and use specialized tools when a lesion looks suspicious. Since skin cancer may resemble a harmless mark, technology helps dermatologists gather more details during an exam. This is how dermatologists use technology to detect cancer:

Digital Dermoscopy

Digital dermoscopy uses a handheld device with light and magnification, and it gives dermatologists a closer view of skin structures. This tool shows pigment patterns, blood vessels, and borders. When a mole has subtle irregular features, the image helps the dermatologist compare visible details with known skin cancer patterns.

Some clinics store dermoscopic images over time, but the goal is not only documentation. Follow-up images help track change in a lesion that does not yet meet biopsy criteria. That matters because an evolving structure may point to melanoma, while a stable structure may support continued monitoring.

Digital dermoscopy typically supports decisions in these situations, and it adds detail beyond a standard visual exam:

New or changing moles
Lesions with uneven color
Spots with irregular borders

Advanced Imaging

Advanced imaging includes tools such as reflectance confocal microscopy, and these systems examine skin at a near-cellular level. The images look below the surface. When a lesion sits in a hard-to-biopsy area, this added detail may help guide the next step.

Some imaging tools map pigment distribution, but others highlight tissue architecture. Dermatologists use that information to separate benign growth patterns from features linked with malignancy. This matters to patients because the exam becomes more targeted and the lesion selection process becomes more precise.

Genomic Tests

Genomic tests study gene activity in a skin sample, and they add another emerging method of clinical evaluation. These tests do not replace the exam. Because some lesions remain difficult to classify under a microscope, genomic data may help clarify whether a mole shows higher-risk behavior.

A dermatologist may order a genomic test after a biopsy, but the choice depends on the lesion type and pathology findings. The report measures specific molecular signals. When the result fits the clinical picture, it may support either closer follow-up or wider treatment planning.

Total Body Scanning

Total body scanning uses high-resolution photography, and it creates a visual map of the skin. Dermatologists use these image sets to monitor patients with many moles. Because small changes are easy to miss from memory alone, side-by-side comparison improves surveillance over time.

This method helps patients with elevated melanoma risk, but it also supports routine follow-up after prior skin cancer. A new spot may stand out more clearly on a full-body record. That helps the dermatologist focus on lesions that have changed in size, shape, or color.

Typical targets for total body scanning include:

Patients with many atypical moles
Patients with a personal history of melanoma
Patients with a strong family history

Visit a Dermatologist

Technology gives dermatologists sharper data, and each tool serves a different role in skin cancer detection. If you notice a new spot or a changing mole, schedule a skin exam with a dermatologist. Bring notes about when the lesion appeared, and mention any bleeding, itching, or rapid growth. Early evaluation helps your dermatologist decide whether imaging, monitoring, or biopsy fits the finding.